Why Capturing Pro Data Matters In Early-Phase Oncology Trials

If you are in the early stages of an oncology trial, there are a lot of questions worth asking and a lot to consider when it comes to your data management. Remote patient monitoring, collecting patient-reported AEs and clinician-reported data limits, and characterizing the dose-tolerability relationships are all essential parts of the process that can be simplified by improving how your organization captures data. Here we illustrate why capturing pro data should be important to you in the early phases of your trial.